Presentation is loading. Please wait.

Presentation is loading. Please wait.

© Copyright 2003 Frost & Sullivan. All Rights Reserved. U.S. Needle-Free Injectables Markets Healthcare Industry Team “As more formulations are developed.

Similar presentations


Presentation on theme: "© Copyright 2003 Frost & Sullivan. All Rights Reserved. U.S. Needle-Free Injectables Markets Healthcare Industry Team “As more formulations are developed."— Presentation transcript:

1 © Copyright 2003 Frost & Sullivan. All Rights Reserved. U.S. Needle-Free Injectables Markets Healthcare Industry Team “As more formulations are developed using needle-free devices, the market revenues are expected to grow. Immunization, insulin, growth hormone, biotechnology drugs, and other medications are expected to spur revenues during the forecast period.”

2 © Copyright 2003 Frost & Sullivan. All Rights Reserved. Industry Trends  Self-Administration drugs using needle-free injectables a growing trend  Smaller, lighter, and smarter needle-free injectables being developed and commercialized  Needle-free injectables being looked as a alternative for mass immunizations  Needlestick prevention considered a top priority by the medical fraternity  More drugs being formulated for usage with needle-free injectable devices

3 © Copyright 2003 Frost & Sullivan. All Rights Reserved. Key Features Frost & Sullivan Provides: Detailed insights into recent developments and trends Drivers, restraints and challenges of industry Analyst insights on emerging issues and new products being developed in the needle-free injectable devices market Market sizing and competitive analysis Market forecasts and opportunity analysis

4 © Copyright 2003 Frost & Sullivan. All Rights Reserved. What We Offer U.S. Coverage Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans

5 © Copyright 2003 Frost & Sullivan. All Rights Reserved. Who Will Benefit?  Current Market Participants  Find out how you can compete now that the landscape is changing  Assess current and future drivers and restraints  Determine and exploit new market share opportunities  New Entrants  Analyze challenges associated with the Drug Delivery market  Calculate time scales for strategy implementation  Position yourself to capitalize on the market’s unmet needs  Investment Community  Analyze long-term strategies of companies in the market  Determine which participants will outperform the competition  Assess attractiveness of investing in the Drug Delivery market

6 © Copyright 2003 Frost & Sullivan. All Rights Reserved. What’s Included The following needle-free injectable devices are included in the research service Reusable, gas powered Single use, spring powered Reusable, spring powered Disposable, single use, spring powered, prefilled (in development)

7 © Copyright 2003 Frost & Sullivan. All Rights Reserved. Key Market Participants  Activa  American Jet Injector  Antares Pharma  Crossject SA  Bioject Inc  American Electromedics  National Medical Products Inc  Medi-Ject  Equidyne Systems Inc now HNS International  Aradigm Corporation  Medical International Technologies  Biovalve Technologies  Penjet Corporation

8 © Copyright 2003 Frost & Sullivan. All Rights Reserved.  Call toll free 877 GO FROST (877.463.7876)  Fax toll free 888.690.3329  E-mail myfrost@frost.com  Visit www.frost.com For More Information


Download ppt "© Copyright 2003 Frost & Sullivan. All Rights Reserved. U.S. Needle-Free Injectables Markets Healthcare Industry Team “As more formulations are developed."

Similar presentations


Ads by Google